Hovione is Expanding Spray Drying Capacity for U.S. Drug Manufacturing
By David Basile, Vice President, Technical Operations - Americas
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
By David Basile, Vice President, Technical Operations - Americas
To address a significant market interest in Advanced APIs (aAPI®), Hovione has increased its range of services and multi-scale facilities in cGMP Spray Drying
Hovione is Growing
Fierce Pharma, 26 March 2026
Hovione is pleased to announce that it has installed a new state-of-the-art Spray Drying facility to address the latest technology in particle design.
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally
EPM Magazine, December 2010
Pharmaceutical Research, August 2014
ASD-HIPROS, Hovione’s Intelligent Proprietary Screening, is the most advanced and accurate tool to identify Amorphous Solid Dispersion formulations by Spray Drying with maximum performance and stability.